ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
4.360
+0.065 (1.51%)
Oct 7, 2026, 4:00 PM EDT - Market closed
SPRY's stock price has decreased by -57.55% in the past year and price targets may not have had time to catch up.
ARS Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $18 → $15 | Buy | Maintains | $18 → $15 | +244.04% | Sep 8, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $30 | Buy | Reiterates | $30 | +588.07% | Aug 14, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 14, 2026 |
| Northland Securities | Northland Securities | Buy Maintains $25 | Buy | Maintains | $25 | +473.39% | Apr 15, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $30 | Buy | Reiterates | $30 | +588.07% | Apr 14, 2026 |